Catherine Moukheibir

Catherine Moukheibir

Directeur/Bestuurslid bij MOONLAKE IMMUNOTHERAPEUTICS

Vermogen: 572 130 $ op 30-06-2024

64 jaar
Health Technology
Finance
Consumer Services

Profiel

Catherine Moukheibir is currently an Independent Director at Ironwood Pharmaceuticals, Inc., an Independent Non-Executive Director at Biotalys NV, a Director at Asceneuron SA, a Director at CMR Surgical Ltd., an Independent Director at DNA Script SAS, an Independent Director at Noema Pharma AG, and an Independent Director at MoonLake Immunotherapeutics.
She previously served as the Chairman & Chief Executive Officer at MedDay Pharmaceuticals SAS, Chairman at Creabilis Therapeutics Srl, Chairman at Creabilis Holdings Ltd., Executive Director-Investment Banking at Morgan Stanley, Director at Calliditas Therapeutics Suisse SA, Director-Capital Markets at Zeltia SA, Independent Director at Ablynx NV, Independent Director at Zealand Pharma A, Independent Director at ABIONYX Pharma SA, Executive Director-Investment Banking at Salomon Smith Barney, Inc., Independent Director at Orphazyme A, Non-Executive Director at Kymab Ltd., Director at Creabilis SA, Director at Calliditas Therapeutics France SAS, Director at Kymab Group Ltd., Independent Non-Executive Director at Oxford Biomedica Plc, and Partner at STJ Advisors LLP.
She also served as the Executive Vice President-Finance & Strategy at Innate Pharma SA, Chief Financial Officer at Movetis NV, and Partner at STJ Advisors LLP.
Ms. Moukheibir holds a graduate degree and an MBA from Yale University.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
18-06-2024 72 944 ( 0.05% ) 475 595 $ 30-06-2024
20-09-2023 25 756 ( 0.02% ) 96 535 $ 30-06-2024
06-06-2024 0 ( -.--% ) - $ 30-06-2024

Actieve functies van Catherine Moukheibir

BedrijvenFunctieBegin
IRONWOOD PHARMACEUTICALS, INC. Directeur/Bestuurslid 01-04-2019
BIOTALYS NV Directeur/Bestuurslid 01-01-2021
MOONLAKE IMMUNOTHERAPEUTICS Directeur/Bestuurslid 05-04-2022
Directeur/Bestuurslid 09-11-2021
Directeur/Bestuurslid 21-10-2021
Directeur/Bestuurslid 16-07-2021
Directeur/Bestuurslid 21-01-2021
Directeur/Bestuurslid -
Alle actieve functies van Catherine Moukheibir

Eerdere bekende functies van Catherine Moukheibir

BedrijvenFunctieEinde
OXFORD BIOMEDICA PLC Directeur/Bestuurslid 24-06-2024
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Catherine Moukheibir in detail bekijken

Opleiding van Catherine Moukheibir

Yale University Graduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Catherine Moukheibir in detail bekijken

Connecties

100 +

Eerstegraads connecties

29

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven9
MORGAN STANLEY

Finance

IRONWOOD PHARMACEUTICALS, INC.

Health Technology

OXFORD BIOMEDICA PLC

Health Technology

INNATE PHARMA

Health Technology

ZEALAND PHARMA A/S

Health Technology

ABIONYX PHARMA

Health Technology

ORPHAZYME A/S

Health Technology

BIOTALYS NV

Process Industries

MOONLAKE IMMUNOTHERAPEUTICS

Health Technology

Bedrijven in privébezit19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Salomon Smith Barney, Inc.

Finance

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Creabilis SA

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Catherine Moukheibir